Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin

Samuel M. Lindner; Christopher B. Fordyce; Anne S. Hellkamp; Yuliya Lokhnygina; Jonathan P. Piccini; Gönter Breithardt; Kenneth W. Mahaffey; Daniel E. Singer; Werner Hacke; Jonathan L. Halperin; Graeme J. Hankey; Scott D. Berkowitz; Christopher C. Nessel; Richard C. Becker; Keith A.A. Fox; Manesh R. Patel

doi:10.1161/CIRCULATIONAHA.116.024666

Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin

Samuel M. Lindner, Christopher B. Fordyce, Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan P. Piccini, Gönter Breithardt, Kenneth W. Mahaffey, Daniel E. Singer, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Scott D. Berkowitz, Christopher C. Nessel, Richard C. Becker, Keith A.A. Fox, Manesh R. Patel

Research output: Contribution to journal › Letter › peer-review

30 Scopus citations

Original language	English
Pages (from-to)	1001-1003
Number of pages	3
Journal	Circulation
Volume	135
Issue number	10
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.116.024666
State	Published - 7 Mar 2017

Keywords

Atrial fibrillation
Renal function

Access to Document

10.1161/CIRCULATIONAHA.116.024666

Cite this

Lindner, S. M., Fordyce, C. B., Hellkamp, A. S., Lokhnygina, Y., Piccini, J. P., Breithardt, G., Mahaffey, K. W., Singer, D. E., Hacke, W., Halperin, J. L., Hankey, G. J., Berkowitz, S. D., Nessel, C. C., Becker, R. C., Fox, K. A. A., & Patel, M. R. (2017). Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin. Circulation, 135(10), 1001-1003. https://doi.org/10.1161/CIRCULATIONAHA.116.024666

@article{7b1855f246574335b04439535c586270,

title = "Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin",

keywords = "Atrial fibrillation, Renal function",

author = "Lindner, {Samuel M.} and Fordyce, {Christopher B.} and Hellkamp, {Anne S.} and Yuliya Lokhnygina and Piccini, {Jonathan P.} and G{\"o}nter Breithardt and Mahaffey, {Kenneth W.} and Singer, {Daniel E.} and Werner Hacke and Halperin, {Jonathan L.} and Hankey, {Graeme J.} and Berkowitz, {Scott D.} and Nessel, {Christopher C.} and Becker, {Richard C.} and Fox, {Keith A.A.} and Patel, {Manesh R.}",

note = "Funding Information: ROCKET AF was funded by Johnson & Johnson and Bayer.",

year = "2017",

month = mar,

day = "7",

doi = "10.1161/CIRCULATIONAHA.116.024666",

language = "English",

volume = "135",

pages = "1001--1003",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "10",

}

Lindner, SM, Fordyce, CB, Hellkamp, AS, Lokhnygina, Y, Piccini, JP, Breithardt, G, Mahaffey, KW, Singer, DE, Hacke, W, Halperin, JL, Hankey, GJ, Berkowitz, SD, Nessel, CC, Becker, RC, Fox, KAA & Patel, MR 2017, 'Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin', Circulation, vol. 135, no. 10, pp. 1001-1003. https://doi.org/10.1161/CIRCULATIONAHA.116.024666

TY - JOUR

T1 - Treatment consistency across levels of baseline renal function with rivaroxaban or warfarin

AU - Lindner, Samuel M.

AU - Fordyce, Christopher B.

AU - Hellkamp, Anne S.

AU - Lokhnygina, Yuliya

AU - Piccini, Jonathan P.

AU - Breithardt, Gönter

AU - Mahaffey, Kenneth W.

AU - Singer, Daniel E.

AU - Hacke, Werner

AU - Halperin, Jonathan L.

AU - Hankey, Graeme J.

AU - Berkowitz, Scott D.

AU - Nessel, Christopher C.

AU - Becker, Richard C.

AU - Fox, Keith A.A.

AU - Patel, Manesh R.

N1 - Funding Information: ROCKET AF was funded by Johnson & Johnson and Bayer.

PY - 2017/3/7

Y1 - 2017/3/7

KW - Atrial fibrillation

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=85033731582&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.116.024666

DO - 10.1161/CIRCULATIONAHA.116.024666

M3 - Letter

C2 - 28264892

AN - SCOPUS:85033731582

SN - 0009-7322

VL - 135

SP - 1001

EP - 1003

JO - Circulation

JF - Circulation

IS - 10

ER -